| __timestamp | Amphastar Pharmaceuticals, Inc. | Intra-Cellular Therapies, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 21226345 |
| Thursday, January 1, 2015 | 37065000 | 87718074 |
| Friday, January 1, 2016 | 41199000 | 93831530 |
| Sunday, January 1, 2017 | 43415000 | 79419009 |
| Monday, January 1, 2018 | 57564000 | 132166913 |
| Tuesday, January 1, 2019 | 68853000 | 89124838 |
| Wednesday, January 1, 2020 | 67229000 | 65782137 |
| Friday, January 1, 2021 | 60932000 | 88845513 |
| Saturday, January 1, 2022 | 74771000 | 134715000 |
| Sunday, January 1, 2023 | 73741000 | 180142000 |
Cracking the code
In the competitive world of biopharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Intra-Cellular Therapies, Inc. and Amphastar Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Intra-Cellular Therapies increased its R&D expenses by over 750%, peaking in 2023 with a staggering 180 million dollars. This reflects their aggressive pursuit of groundbreaking therapies. In contrast, Amphastar Pharmaceuticals maintained a more steady growth, with a 160% increase over the same period, reaching approximately 74 million dollars in 2023. This steady approach suggests a focus on incremental innovation and optimization. The data highlights the diverse strategies within the industry, where some companies prioritize rapid advancement while others focus on sustainable growth.
Research and Development Investment: Zoetis Inc. vs Intra-Cellular Therapies, Inc.
Research and Development Expenses Breakdown: argenx SE vs Intra-Cellular Therapies, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Opthea Limited
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amicus Therapeutics, Inc.
Comparing Innovation Spending: Sarepta Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Halozyme Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Opthea Limited vs Amphastar Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. or MannKind Corporation: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Amphastar Pharmaceuticals, Inc. and Celldex Therapeutics, Inc.
R&D Insights: How Amphastar Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. Allocate Funds